secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2026-03-11T23:59:59+00:00
Accession:  0001493152-26-009701
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi closes $6M public offering; existing warrants amended to $0.50 exercise price
--------------------------------------------------------------------------------

- Gross proceeds of $6.03M from 12,094,631 units sold (including full over-allotment exercise).
- Each unit priced at $0.50 and consists of common stock (or pre-funded warrant) plus Series J (5 yr), K (1 yr) and L (6 mo) warrants.
- Existing warrants for ~2.97M shares (Series G/H/I) amended to exercise price of $0.50 per share.
- Company had 10,545,725 common shares outstanding as of March 11, 2026, post-offering.
- Proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315226009701/0001493152-26-009701-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315226009701/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-009701

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer